European Journal of Heart Failure
DECEMBER 20, 2023
Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.
DAIC
JUNE 19, 2024
Getty Images milla1cf Wed, 06/19/2024 - 20:54 June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. The new study was motivated by a need to fill that gap, Rao said. They found that exposure to PM2.5,
American College of Cardiology
NOVEMBER 22, 2024
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment.
Medical Xpress - Cardiology
DECEMBER 13, 2024
The devastating news of a cancer diagnosis understandably makes doctors and patients focus on the cancer itself.
DAIC
FEBRUARY 28, 2024
The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors. “We Wendy Bottinor, MD.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
This is the first case series to shed light on the application of cangrelor in cancer patients needing to pause dual antiplatelet therapy for a range of medical interventions, marking it as a pioneering effort in this domain.
Circulation: Genomic and Precision Medicine
FEBRUARY 24, 2025
Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease and its treatments.
Expert insights. Personalized for you.
75 
Let's personalize your content